Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Clinical Decision Support System AMPEL for Laboratory Diagnostics: Implementation and Technical Evaluation.
Walter Costa MB, Wernsdorfer M, Kehrer A, Voigt M, Cundius C, Federbusch M, Eckelt F, Remmler J, Schmidt M, Pehnke S, Gärtner C, Wehner M, Isermann B, Richter H, Telle J, Kaiser T. Walter Costa MB, et al. Among authors: telle j. JMIR Med Inform. 2021 Jun 3;9(6):e20407. doi: 10.2196/20407. JMIR Med Inform. 2021. PMID: 34081013 Free PMC article.
Acute kidney injury and its progression in hospitalized patients-Results from a retrospective multicentre cohort study with a digital decision support system.
Kister TS, Remmler J, Schmidt M, Federbusch M, Eckelt F, Isermann B, Richter H, Wehner M, Krause U, Halbritter J, Cundius C, Voigt M, Kehrer A, Telle JM, Kaiser T. Kister TS, et al. Among authors: telle jm. PLoS One. 2021 Jul 12;16(7):e0254608. doi: 10.1371/journal.pone.0254608. eCollection 2021. PLoS One. 2021. PMID: 34252151 Free PMC article.
Correction to: LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial.
Ohlmann CH, Jäschke M, Jaehnig P, Krege S, Gschwend J, Rexer H, Junker K, Zillmann R, Rüssel C, Hellmis E, Suttmann H, Janssen M, Marin J, Hübner A, Mathers M, Gleißner J, Scheffler M, Feyerabend S, Telle J, Klier J, Stöckle M. Ohlmann CH, et al. Among authors: telle j. Prostate Cancer Prostatic Dis. 2023 Dec;26(4):812. doi: 10.1038/s41391-023-00682-2. Prostate Cancer Prostatic Dis. 2023. PMID: 37253975 Free PMC article. No abstract available.
LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial.
Ohlmann CH, Jäschke M, Jaehnig P, Krege S, Gschwend J, Rexer H, Junker K, Zillmann R, Rüssel C, Hellmis E, Suttmann H, Janssen M, Marin J, Hübner A, Mathers M, Gleißner J, Scheffler M, Feyerabend S, Telle J, Klier J, Stöckle M. Ohlmann CH, et al. Among authors: telle j. Prostate Cancer Prostatic Dis. 2022 Apr;25(4):778-784. doi: 10.1038/s41391-022-00533-6. Epub 2022 Apr 16. Prostate Cancer Prostatic Dis. 2022. PMID: 35430584 Free PMC article. Clinical Trial.
Effect of dutasteride on the risk of prostate cancer.
Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, Pettaway CA, Tammela TL, Teloken C, Tindall DJ, Somerville MC, Wilson TH, Fowler IL, Rittmaster RS; REDUCE Study Group. Andriole GL, et al. N Engl J Med. 2010 Apr 1;362(13):1192-202. doi: 10.1056/NEJMoa0908127. N Engl J Med. 2010. PMID: 20357281 Free article. Clinical Trial.
[Paracelsus and pseudo-Paracelsus letters].
Telle J. Telle J. Nova Acta Paracelsica. 2006-2007;20-21:147-64. Nova Acta Paracelsica. 2006. PMID: 18351278 German. No abstract available.
[The prescription as literature].
Telle J. Telle J. Ber Wiss. 2003 Dec;26(4):251-47. doi: 10.1002/bewi.200390074. Ber Wiss. 2003. PMID: 14765522 German.
42 results